| Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells N Ji, Y Yang, CY Cai, ZN Lei, JQ Wang, P Gupta, S Shukla, SV Ambudkar, ... Cancer letters 440, 82-93, 2019 | 99 | 2019 |
| Proteomics technologies for cancer liquid biopsies Z Ding, N Wang, N Ji, ZS Chen Molecular Cancer 21 (1), 53, 2022 | 91 | 2022 |
| VS-4718 antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells by inhibiting the efflux function of ABC transporters N Ji, Y Yang, CY Cai, ZN Lei, JQ Wang, P Gupta, QX Teng, ZS Chen, ... Frontiers in Pharmacology 9, 1236, 2018 | 50 | 2018 |
| Ulixertinib (BVD-523) antagonizes ABCB1-and ABCG2-mediated chemotherapeutic drug resistance N Ji, Y Yang, ZN Lei, CY Cai, JQ Wang, P Gupta, X Xian, DH Yang, ... Biochemical Pharmacology 158, 274-285, 2018 | 49 | 2018 |
| Venetoclax, a BCL-2 inhibitor, enhances the efficacy of chemotherapeutic agents in wild-type ABCG2-overexpression-mediated MDR cancer cells JQ Wang, JY Li, QX Teng, ZN Lei, N Ji, Q Cui, L Zeng, Y Pan, DH Yang, ... Cancers 12 (2), 466, 2020 | 44 | 2020 |
| Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro Y Yang, N Ji, QX Teng, CY Cai, JQ Wang, ZX Wu, ZN Lei, S Lusvarghi, ... Frontiers in oncology 10, 700, 2020 | 34 | 2020 |
| Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible Q Cui, Y Yang, N Ji, JQ Wang, L Ren, DH Yang, ZS Chen Future Medicinal Chemistry 11 (4), 323-336, 2019 | 33 | 2019 |
| Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study N Ji, Y Yang, CY Cai, JQ Wang, ZN Lei, ZX Wu, Q Cui, DH Yang, ZS Chen, ... Frontiers in oncology 9, 514, 2019 | 32 | 2019 |
| Roburic Acid Suppresses NO and IL-6 Production via Targeting NF-κB and MAPK Pathway in RAW264.7 Cells Y Chen, N Ji, S Pan, Z Zhang, R Wang, Y Qiu, M Jin, D Kong Inflammation 40, 1959-1966, 2017 | 27 | 2017 |
| Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor Y Yang, N Ji, CY Cai, JQ Wang, ZN Lei, QX Teng, ZX Wu, Q Cui, Y Pan, ... Cancer Communications 40 (7), 285-300, 2020 | 26 | 2020 |
| Inhibitory effect of taxifolin on mast cell activation and mast cell-mediated allergic inflammatory response S Pan, X Zhao, N Ji, C Shao, B Fu, Z Zhang, R Wang, Y Qiu, M Jin, ... International Immunopharmacology 71, 205-214, 2019 | 26 | 2019 |
| Glesatinib, a c-MET/SMO dual inhibitor, antagonizes P-glycoprotein mediated multidrug resistance in cancer cells Q Cui, CY Cai, HL Gao, L Ren, N Ji, P Gupta, Y Yang, S Shukla, ... Frontiers in Oncology 9, 313, 2019 | 26 | 2019 |
| Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1-and ABCG2-mediated multidrug resistance JQ Wang, B Wang, ZN Lei, QX Teng, JY Li, W Zhang, N Ji, CY Cai, LY Ma, ... European journal of pharmacology 863, 172611, 2019 | 23 | 2019 |
| Chk1 inhibitor MK-8776 restores the sensitivity of chemotherapeutics in P-glycoprotein overexpressing cancer cells Q Cui, CY Cai, JQ Wang, S Zhang, P Gupta, N Ji, Y Yang, X Dong, ... International Journal of Molecular Sciences 20 (17), 4095, 2019 | 22 | 2019 |
| Reversal of cancer multidrug resistance (MDR) mediated by ATP-binding cassette transporter G2 (ABCG2) by AZ-628, a RAF kinase inhibitor JQ Wang, QX Teng, ZN Lei, N Ji, Q Cui, H Fu, L Lin, DH Yang, YF Fan, ... Frontiers in Cell and Developmental Biology 8, 601400, 2020 | 21 | 2020 |
| Alisol B 23-acetate inhibits IgE/Ag-mediated mast cell activation and allergic reaction C Shao, B Fu, N Ji, S Pan, X Zhao, Z Zhang, Y Qiu, R Wang, M Jin, K Wen, ... International Journal of Molecular Sciences 19 (12), 4092, 2018 | 16 | 2018 |
| Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression S Wang, L Zhou, N Ji, C Sun, L Sun, J Sun, Y Du, N Zhang, Y Li, W Liu, ... Drug Resistance Updates 69, 100976, 2023 | 14 | 2023 |
| Insights on the structure–function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies JQ Wang, Q Cui, ZN Lei, QX Teng, N Ji, L Lin, Z Liu, ZS Chen MedComm 2 (2), 221-235, 2021 | 12 | 2021 |
| Spinacetin suppresses the mast cell activation and passive cutaneous anaphylaxis in mouse model N Ji, S Pan, C Shao, Y Chen, Z Zhang, R Wang, Y Qiu, M Jin, D Kong Frontiers in Pharmacology 9, 824, 2018 | 12 | 2018 |
| 1, 6-O, O-Diacetylbritannilactone inhibits eotaxin-1 and ALOX15 expression through inactivation of STAT6 in A549 cells X Chen, N Ji, N Qin, S Tang, R Wang, Y Qiu, H Duan, D Kong, M Jin Inflammation 40 (6), 1967-1974, 2017 | 10 | 2017 |
Zhe-Sheng ChenCollege of Pharmacy and Health Sciences, St. John's UniversityVerified email at stjohns.edu
